UROLOGIC CANCER
Clinical trials for UROLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC CANCER trials appear
Sign up with your email to follow new studies for UROLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug shows promise for rare genetic cancers, but study halted early
Disease control TerminatedThis study tested the drug niraparib in 22 adults with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific PALB2 gene mutation. The goal was to see if the drug could shrink tumors or slow cancer growth. The study was stopped early, so results are …
Matched conditions: UROLOGIC CANCER
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Quit smoking before surgery to cut complications, study suggests
Disease control TerminatedThis study looked at whether a structured smoking cessation program, started four weeks before surgery, could reduce complications in smokers undergoing intermediate to high-risk operations. Researchers planned to enroll 251 adults who smoked daily and were scheduled for surgerie…
Matched conditions: UROLOGIC CANCER
Phase: NA • Sponsor: Luzerner Kantonsspital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC